DGAP-News: MediClin AG / Key word(s): 9-month figures MediClin AG: Earnings target für the 2014 FY is lifted due to a better business development compared to the fourth quarter 2013 10.11.2014 / 12:00 --------------------------------------------------------------------- MediClin: Earnings target für the 2014 FY is lifted due to a better business development compared to the fourth quarter 2013 Offenburg, November 10, 2014 - MEDICLIN Aktiengesellschaft (MediClin) specifies the outlook for the 2014 FY due to the still good business development in October as follows: The business performance gives rise to the assumption that the sales growth of 3.0 % that is forecast for the Group will be reached, as well as the forecasts for the post-acute (+4.5 % to +5.0 %) and acute (+1.0 % to +1.5 %) segments. The earnings forecast for the Group is lifted: Group EBIT is expected in the range of EUR 10 mill. to EUR 12 mill., mainly based on the good result of the post-acute segment. Provided that the seasonal decline in the occupancy rate is only moderate in December 2014, the segment result should come out between EUR 10 mill and EUR 12 mill. The result of the acute segment will be within the forecast range of EUR 8 mill. and EUR 9 mill. The segment other activities will show a negative segment-EBIT as in the previous year. About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 10 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,800 employees. MediClin ─ a company of the Asklepios Group --------------------------------------------------------------------- 10.11.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MediClin AG Okenstraße 27 77652 Offenburg Germany Phone: +49 (0)781 488-189 Fax: +49 (0)781 488-184 E-mail: [email protected] Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 296136 10.11.2014